- Home
- HHS vs BNGO Comparison
HHS vs BNGO Comparison
Compare HHS & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HHS
- BNGO
- Stock Information
- Founded
- HHS 1923
- BNGO 2003
- Country
- HHS United States
- BNGO United States
- Employees
- HHS N/A
- BNGO N/A
- Industry
- HHS Advertising
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- HHS Consumer Discretionary
- BNGO Industrials
- Exchange
- HHS Nasdaq
- BNGO Nasdaq
- Market Cap
- HHS 27.3M
- BNGO 24.3M
- IPO Year
- HHS N/A
- BNGO 2018
- Fundamental
- Price
- HHS $3.69
- BNGO $1.79
- Analyst Decision
- HHS
- BNGO Buy
- Analyst Count
- HHS 0
- BNGO 4
- Target Price
- HHS N/A
- BNGO $7.67
- AVG Volume (30 Days)
- HHS 20.9K
- BNGO 1.2M
- Earning Date
- HHS 11-13-2025
- BNGO 11-12-2025
- Dividend Yield
- HHS N/A
- BNGO N/A
- EPS Growth
- HHS N/A
- BNGO N/A
- EPS
- HHS N/A
- BNGO N/A
- Revenue
- HHS $174,951,000.00
- BNGO $27,426,000.00
- Revenue This Year
- HHS $6.54
- BNGO N/A
- Revenue Next Year
- HHS N/A
- BNGO $24.54
- P/E Ratio
- HHS N/A
- BNGO N/A
- Revenue Growth
- HHS N/A
- BNGO N/A
- 52 Week Low
- HHS $3.06
- BNGO $1.50
- 52 Week High
- HHS $7.72
- BNGO $30.52
- Technical
- Relative Strength Index (RSI)
- HHS 51.90
- BNGO 29.99
- Support Level
- HHS $3.67
- BNGO $1.50
- Resistance Level
- HHS $3.83
- BNGO $1.90
- Average True Range (ATR)
- HHS 0.10
- BNGO 0.45
- MACD
- HHS 0.01
- BNGO -0.30
- Stochastic Oscillator
- HHS 60.81
- BNGO 7.25
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.